LB Pharmaceuticals Inc
LBRX
$29.66
-$1.75-5.57%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 365.64M | 295.21M | 314.48M | 14.23M | 28.00M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.43M | 2.46M | 1.92M | 556.00K | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 20.01M | 10.76M | -- | -- | -- |
| Total Current Assets | 389.07M | 308.43M | 316.40M | 14.78M | -- |
|
|
|||||
| Total Current Assets | 389.07M | 308.43M | 316.40M | 14.78M | -- |
| Net Property, Plant & Equipment | 3.63M | 3.73M | 3.83M | 3.96M | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 776.00K | 770.00K | 512.00K | 508.00K | -- |
| Total Assets | 393.48M | 312.93M | 320.75M | 19.25M | -- |
|
|
|||||
| Total Accounts Payable | 7.12M | 2.13M | 2.59M | 635.00K | -- |
| Total Accrued Expenses | 3.06M | 4.59M | 3.33M | 2.54M | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 730.00K | 730.00K | 730.00K | 730.00K | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 10.91M | 7.44M | 6.65M | 3.91M | -- |
|
|
|||||
| Total Current Liabilities | 10.91M | 7.44M | 6.65M | 3.91M | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.74M | 2.84M | 2.94M | 3.03M | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.14M | 1.34M | 942.00K | 1.93M | -- |
| Total Liabilities | 14.79M | 11.62M | 10.53M | 8.86M | -- |
|
|
|||||
| Common Stock & APIC | 527.07M | 430.67M | 428.33M | 10.63M | -- |
| Retained Earnings | -148.58M | -129.53M | -118.06M | -114.50M | -- |
| Treasury Stock & Other | 208.00K | 168.00K | -53.00K | -- | -- |
| Total Common Equity | 378.69M | 301.31M | 310.22M | -103.87M | -94.55M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | 114.26M | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | 114.26M | 114.26M |
|
|
|||||
| Total Common Equity | 378.69M | 301.31M | 310.22M | -103.87M | -94.55M |
| Total Preferred Equity | -- | -- | -- | 114.26M | 114.26M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 378.69M | 301.31M | 310.22M | 10.39M | 19.71M |
|
|
|||||